Education and Training
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
In this study, patients with advanced solid tumors will undergo [18F]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: [18F]F-AraG
Eligibility
Inclusion Criteria:
- Solid tumor with planned CkIT
- Must be >18 years old
- Signed Informed Consent Form
- Patient must have two qualifying lesions
Exclusion Criteria:
- Patient is pregnant or breast feeding
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Maria Isabel Galvez Leonio
650-723-0371
Not Recruiting